Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.
Saved in:
| Title: | Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer. |
|---|---|
| Authors: | Kilpatrick M; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA. Electronic address: mattie.kilpatrick@emoryhealthcare.org., Gundersen P; Department of Pharmaceutical Services, Intermountain Health, Salt Lake City, UT., O'Reilly K; Department of Pharmaceutical Services, Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, GA., Goyal S; Biostatistican Department, Winship Cancer Institute/Emory University, Atlanta, GA., Sun L; Department of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA., Kim P; Medical Affairs, Amgen Inc, Thousand Oaks, CA., Carlisle J; Department of Hematology/Oncology, Emory School of Medicine, Winship Cancer Institute, Atlanta, GA. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2026 Jul; Vol. 27 (6), pp. 11-18. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0690 |
|---|---|
| DOI: | 10.1016/j.cllc.2026.05.001 |
